3.91
price down icon1.76%   -0.07
after-market After Hours: 3.91
loading
Sight Sciences Inc stock is traded at $3.91, with a volume of 92,751. It is down -1.76% in the last 24 hours and down -24.81% over the past month. Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.
See More
Previous Close:
$3.98
Open:
$3.97
24h Volume:
92,751
Relative Volume:
0.47
Market Cap:
$203.10M
Revenue:
$81.06M
Net Income/Loss:
$-55.55M
P/E Ratio:
-2.6781
EPS:
-1.46
Net Cash Flow:
$-47.98M
1W Performance:
+4.83%
1M Performance:
-24.81%
6M Performance:
-29.80%
1Y Performance:
+16.72%
1-Day Range:
Value
$3.90
$4.11
1-Week Range:
Value
$3.72
$4.45
52-Week Range:
Value
$2.58
$8.45

Sight Sciences Inc Stock (SGHT) Company Profile

Name
Name
Sight Sciences Inc
Name
Phone
(415) 889-0550
Name
Address
4040 CAMPBELL AVE,, MENLO PARK
Name
Employee
214
Name
Twitter
Name
Next Earnings Date
2024-11-07
Name
Latest SEC Filings
Name
SGHT's Discussions on Twitter

Compare SGHT with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Medical Devices icon
SGHT
Sight Sciences Inc
3.91 203.10M 81.06M -55.55M -47.98M -1.46
Medical Devices icon
ABT
Abbott Laboratories
118.95 208.18B 41.22B 5.77B 6.49B 2.94
Medical Devices icon
SYK
Stryker Corp
388.14 148.70B 21.97B 3.59B 3.21B 6.74
Medical Devices icon
BSX
Boston Scientific Corp
90.75 133.32B 15.91B 1.79B 1.89B 0.82
Medical Devices icon
MDT
Medtronic Plc
86.27 111.27B 33.00B 4.29B 5.50B 2.71
Medical Devices icon
EW
Edwards Lifesciences Corp
72.07 42.66B 6.60B 4.16B 490.10M 2.34

Sight Sciences Inc Stock (SGHT) Upgrades & Downgrades

Date Action Analyst Rating Change
Nov-04-24 Downgrade Lake Street Buy → Hold
Aug-21-24 Initiated Lake Street Buy
Sep-12-23 Downgrade BofA Securities Neutral → Underperform
Sep-12-23 Downgrade Piper Sandler Overweight → Neutral
Sep-12-23 Downgrade William Blair Outperform → Mkt Perform
Aug-24-23 Downgrade Morgan Stanley Overweight → Equal-Weight
Jul-10-23 Downgrade Citigroup Buy → Neutral
Jan-06-23 Upgrade Stifel Hold → Buy
Oct-04-22 Initiated Needham Hold
Jul-26-22 Initiated Stifel Hold
Feb-03-22 Initiated William Blair Outperform
Jan-07-22 Upgrade Morgan Stanley Equal-Weight → Overweight
View All

Sight Sciences Inc Stock (SGHT) Latest News

pulisher
Nov 26, 2024

Millrace Asset Group Inc. Acquires New Shares in Sight Sciences, Inc. (NASDAQ:SGHT) - MarketBeat

Nov 26, 2024
pulisher
Nov 26, 2024

GSA Capital Partners LLP Invests $136,000 in Sight Sciences, Inc. (NASDAQ:SGHT) - Defense World

Nov 26, 2024
pulisher
Nov 24, 2024

Independent Chairman Of Sight Sciences Sold 25% Of Their Shares - Simply Wall St

Nov 24, 2024
pulisher
Nov 22, 2024

Hedge Fund and Insider Trading News: Ken Griffin, Bridgewater Associates, AQR Capital Management, Brookfield Asset Management, Sight Sciences Inc (SGHT), Royal Caribbean Cruises Ltd (RCL), and More - Insider Monkey

Nov 22, 2024
pulisher
Nov 21, 2024

Sight sciences EVP Manohar Raheja acquires $7,400 in stock By Investing.com - Investing.com Nigeria

Nov 21, 2024
pulisher
Nov 21, 2024

Sight sciences EVP Manohar Raheja acquires $7,400 in stock - Investing.com

Nov 21, 2024
pulisher
Nov 21, 2024

Sight Sciences director Encrantz sells $2.06 million in stock - Investing.com India

Nov 21, 2024
pulisher
Nov 20, 2024

SGHTSight Sciences, Inc. Latest Stock News & Market Updates - StockTitan

Nov 20, 2024
pulisher
Nov 20, 2024

Top 3 Health Care Stocks You'll Regret Missing In November - MSN

Nov 20, 2024
pulisher
Nov 19, 2024

Sight Sciences to Present at the Piper Sandler 36th Annual Healthcare Conference - The Manila Times

Nov 19, 2024
pulisher
Nov 19, 2024

Sight Sciences to Present at Piper Sandler Healthcare Conference in December | SGHT Stock News - StockTitan

Nov 19, 2024
pulisher
Nov 13, 2024

Sight Sciences, Inc. (NASDAQ:SGHT) Stocks Pounded By 26% But Not Lagging Industry On Growth Or Pricing - Simply Wall St

Nov 13, 2024
pulisher
Nov 13, 2024

Sight Sciences FY2024 EPS Estimate Raised by William Blair - MarketBeat

Nov 13, 2024
pulisher
Nov 13, 2024

Sight Sciences Announces New Leadership Appointments - Vision Monday

Nov 13, 2024
pulisher
Nov 12, 2024

Sight Sciences price target lowered to $5 from $7 at Morgan Stanley - Yahoo Finance

Nov 12, 2024
pulisher
Nov 12, 2024

Sight Sciences, Inc. (SGHT) Reports Q3 Loss, Misses Revenue Estimates - MSN

Nov 12, 2024
pulisher
Nov 11, 2024

Sight Sciences (NASDAQ:SGHT) Price Target Lowered to $5.00 at Morgan Stanley - MarketBeat

Nov 11, 2024
pulisher
Nov 11, 2024

Sight Sciences, Inc. (NASDAQ:SGHT) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 11, 2024
pulisher
Nov 11, 2024

Sight Sciences Reports Third Quarter Results and Updates its Full Year 2024 Adjusted Operating Expense Guidance - Vision Monday

Nov 11, 2024
pulisher
Nov 09, 2024

South Africa Dry Eye Treatment Devices Market Size & Outlook, 2030 - Grand View Research

Nov 09, 2024
pulisher
Nov 09, 2024

Sight Sciences Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance

Nov 09, 2024
pulisher
Nov 09, 2024

Sight Sciences stock price target cut on Q3 revenue headwinds - Investing.com

Nov 09, 2024
pulisher
Nov 08, 2024

Sight Sciences (NASDAQ:SGHT) Receives "Neutral" Rating from Piper Sandler - MarketBeat

Nov 08, 2024
pulisher
Nov 08, 2024

Sight Sciences' (SGHT) "Hold" Rating Reiterated at Needham & Company LLC - MarketBeat

Nov 08, 2024
pulisher
Nov 08, 2024

Sight Sciences stock price target cut on Q3 revenue headwinds By Investing.com - Investing.com UK

Nov 08, 2024
pulisher
Nov 08, 2024

Sight Sciences Inc. (SGHT) PT Lowered to $5.50 at Piper Sandler - StreetInsider.com

Nov 08, 2024
pulisher
Nov 08, 2024

Sight Sciences, Inc. (SGHT) Misses Q3 EPS by 1c - StreetInsider.com

Nov 08, 2024
pulisher
Nov 08, 2024

Sight Sciences Inc (SGHT) Q3 2024 Earnings Call Highlights: Navigating Challenges with ... By GuruFocus - Investing.com Canada

Nov 08, 2024
pulisher
Nov 08, 2024

Sight Sciences Reports Modest Growth and Optimistic Outlook - TipRanks

Nov 08, 2024
pulisher
Nov 07, 2024

Sight Sciences Appoints MK Raheja as Executive Vice President, Research and Development and Brenton Taylor as Executive Vice President, Operations - The Manila Times

Nov 07, 2024
pulisher
Nov 07, 2024

Sight Sciences Reports Third Quarter 2024 Financial Results and Updates its Full Year 2024 Adjusted Operating Expense Guidance - The Manila Times

Nov 07, 2024
pulisher
Nov 07, 2024

Sight Sciences Reports Third Quarter 2024 Financial Results - GlobeNewswire

Nov 07, 2024
pulisher
Nov 07, 2024

Sight Sciences Appoints MK Raheja as Executive Vice - GlobeNewswire

Nov 07, 2024
pulisher
Nov 07, 2024

Sight Sciences Strengthens Leadership: Ophthalmic Innovation Expert & Inogen Co-Founder Join Executive Team | SGHT Stock News - StockTitan

Nov 07, 2024
pulisher
Nov 07, 2024

Sight Sciences Reports Revenue Growth and Leadership Change - TipRanks

Nov 07, 2024
pulisher
Nov 06, 2024

Sight Sciences Inc (SGHT) Q3 2024 Earnings Report Preview: What To Expect - Yahoo Finance

Nov 06, 2024
pulisher
Nov 05, 2024

Lake Street cuts Sight Sciences stock rating to hold amid market challenges - Investing.com Canada

Nov 05, 2024
pulisher
Nov 04, 2024

Lake Street Capital Markets Downgrades Sight Sciences Inc. (SGHT) to Hold - StreetInsider.com

Nov 04, 2024
pulisher
Nov 04, 2024

Sight Sciences (NASDAQ:SGHT) Rating Lowered to "Hold" at Lake Street Capital - MarketBeat

Nov 04, 2024
pulisher
Nov 04, 2024

Rezolute, Inc. (NASDAQ:RZLT) Receives $11.57 Consensus Target Price from Analysts - Defense World

Nov 04, 2024
pulisher
Oct 31, 2024

Global Dry Eye Disease Treatment Market Projected to Cross USD 9 Billion by 2030 | DelveInsight - The Malaysian Reserve

Oct 31, 2024
pulisher
Oct 31, 2024

Sight Sciences (SGHT) Scheduled to Post Earnings on Thursday - MarketBeat

Oct 31, 2024
pulisher
Oct 31, 2024

Analysts Estimate Tandem Diabetes Care, Inc. (TNDM) to Report a Decline in Earnings: What to Look Out for - MSN

Oct 31, 2024
pulisher
Oct 29, 2024

Microsoft Co. (NASDAQ:MSFT) Shares Acquired by Parametrica Management Ltd - Defense World

Oct 29, 2024
pulisher
Oct 28, 2024

KCK LTD.'s Strategic Reduction in NeuroPace Inc Shares - Yahoo Finance

Oct 28, 2024
pulisher
Oct 24, 2024

KCK LTD. Adjusts Stake in NeuroPace Inc - GuruFocus.com

Oct 24, 2024
pulisher
Oct 23, 2024

Preview: Zynex's Earnings - Benzinga

Oct 23, 2024
pulisher
Oct 22, 2024

Sight Sciences CCO Matthew Link sells $244,900 in stock - Investing.com India

Oct 22, 2024
pulisher
Oct 21, 2024

Sight Sciences, Inc. (NASDAQ:SGHT) Insider Sells $122,471.91 in Stock - MarketBeat

Oct 21, 2024
pulisher
Oct 21, 2024

Sight Sciences CCO Matthew Link sells $244,900 in stock By Investing.com - Investing.com South Africa

Oct 21, 2024
pulisher
Oct 21, 2024

The Manufacturers Life Insurance Company Increases Stock Holdings in Erasca, Inc. (NASDAQ:ERAS) - Defense World

Oct 21, 2024

Sight Sciences Inc Stock (SGHT) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
medical_devices STE
$217.47
price up icon 0.65%
medical_devices ZBH
$112.02
price up icon 1.25%
medical_devices PHG
$27.15
price up icon 0.89%
$78.10
price up icon 0.21%
$83.00
price up icon 0.59%
medical_devices EW
$72.07
price up icon 0.73%
Cap:     |  Volume (24h):